Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

im the most ignorant person here - and curious abo

Message Board Public Reply | Private Reply | Keep | Replies (3)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 154361
(Total Views: 487)
Posted On: 06/05/2025 2:22:02 PM
Posted By: seemingly-harmless
Re: craigakess #153865
im the most ignorant person here - and curious about the evolution and databases of off label use of approved drugs, in general, across the industry - could be an interesting book subject..... and does it ever lead to being approved for the off label indication?

the ozempic / wegovy semaglutide story is different here because the side effect of weight loss in diabetes patients was a directly observable obvious positive(?) benefit of using the drug. im more interested in theoretical off label uses that werent simply an accidental observable result of use...although many have commented here wondering if the 1000 or so HIV patients that got to use leronlimab for years at a time had any other observable benefits like lower covid deaths, lower rates of metastatic cancers, lower HIV transmission rates, lower levels of liver fibrosis etc etc etc...all data that was never collected apparently? i understand that even the patients themselves were difficult to track down as per the amarex nonsense.

how does an approved drug even start to be used off label for a different indication in the first place? is it patient driven demand or is it scientist/doctor driven? is it always an observable beneficial side effect? is it in the drug companys' benefit, or even legal, to sell to the off label patients at a discount, as the insurance cos refuse to pay?

is there a database of off label drugs, their off label indications, and their sales numbers?

i have a sneaky suspicion that once leronlimab is approved for its first indication, off label prescription numbers will be huge. for a long list of indications.

Quote:
Pardon my potential ignorance, but how could a licensee "mothball a LL indication"?

Once a drug is approved by the FDA for at least one use, healthcare providers can use their medical judgment to prescribe it for other medically appropriate purposes, even if those uses are not on the approved labeling.

Off-label prescribing is a common practice in medicine, with some estimates suggesting that 1 in 5 prescriptions written are for off-label uses. Of course CYDY (or the licensee) could not tout LL for an indication that it was not approved for.

Sure, maybe some insurance companies won't pay for it off-label, but that won't mean that people cannot get it some way.



(1)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us